Delivery Order SPE2DB20D2104-SPE2DB22FR41C
Award Date 1/4/22
Potential Completion Date 1/5/22
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lubiprostone 8 MCG Capsules. The $1,358.73 firm fixed-price contract has an ultimate completion date of October 19, 2021. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lubiprostone 24 MCG Capsule 60S. The contract has a firm fixed price of $3,951.52 and an ultimate completion date of August 19, 2021. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). The contract is not designated with any...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lubiprostone 8 mcg capsules. The $1,297.56 firm-fixed-price contract has a completion date of September 9, 2022 and was awarded on September 8, 2022. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide Lubiprostone 24 MCG capsules. The contract is valued at $5,720.58 and has a completion date of February 15, 2022. AmerisourceBergen Drug Corporation is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). The contract is not designated with a...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Lubiprostone 24 MCG Capsules. The $2,891.20 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of August 25, 2021. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The IDC enables the DLA to efficiently...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Lubiprostone 24 MCG Capsule 60S, a pharmaceutical product. The $3,999.85 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 5, 2022. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lubiprostone 24 MCG Capsule 60s. The contract has a ceiling value of $1,299.26 and is a Firm Fixed Price Delivery Order. There was no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 26, 2023. The $1,672.66 firm fixed-price delivery order is for the supply of 60 units of the drug Lubiprostone 24 MCG Capsule. The contract has a performance period through May 30, 2023 and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of Lubiprostone 24 MCG capsules for the Defense Logistics Agency (DLA). The $11,321.71 firm fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
- This federal contract award is for the delivery of LUBIPROSTONE 24 MCG CAPSULE 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price delivery order contract valued at $6,163.35. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that serves as a key supplier to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract...